Two to six companies, their latest annual figures side by side, from SEC filings.
| Figure | PACBPacific Biosciences of California, Inc.FY2025 · Dec |
|---|---|
| Revenue | $160.01M |
| Revenue, yoy | +3.9% |
| Net income | $546.38M |
| Net income, yoy | −76.3% |
| Net margin | -341.5% |
| Free cash flow | $113.92M |
| FCF margin | -71.2% |
| EPS, diluted | $1.82 |
Add another company.